NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-220-1995-0-PCT-02 No_Patent_Title PCT PCT PCT/US96/014704 Expired
NCI E-035-1994-1-NZ-16 ISOLATION OF CELLULAR MATERIAL UNDER MICROSCOPIC VISUALIZATION NZ National Stage 282276 Abandoned
NCI E-002-1993-0-US-03 COLON MUCOSA GENE HAVING DOWN-REGULATED EXPRESSION IN COLON ADENOMAS AND ADENOCARCINOMAS US DIV 08/711,928 5831015 Abandoned PDF
NIDDK E-145-1995-0-US-01 USE OF FUNCTIONAL N-METHYLE-D-ASPARTATE ANTAGONISTS TO AMELIORATE OR PREVENT AMINOGLYCOSIDE-INDUCED OTOTOXICITY US ORD 08/712,477 Abandoned
NIDCR E-066-1996-0-US-01 AAV4 VECTOR AND USES THEREOF US 60/025,934 Abandoned
NINDS E-249-1989-0-US-03 CLONED GENES FOR HUMAN DOPAMINE D2 RECEPTORS AND CELL LINES EXPRESSING SAME US DIV 08/709,298 6214615 Expired PDF
NIEHS E-215-1995-0-PCT-02 COMPOSITIONS COMPRISING VITAMIN F (PHYTANIC ACID) PCT PCT PCT/US96/15205 Abandoned
NCI E-167-1996-0-US-01 METHOD OF STIMULATING AN IMMUNE RESPONSE US ORD 60/025,882 Abandoned
NCI E-170-1996-0-US-01 THERAPEUTIC CHEMOKINE ANTAGONISTS US 60/024,708 Abandoned
NCI E-186-1995-0-CA-02 MUTANT AEQUOREA VICTORIA FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE
gp 		CA ORD 2184763 Abandoned
NINDS E-231-1994-2-US-01 METHOD OF REDUCING PERIVASCULAR LESIONS USING INSULIN-LIKE GROWTH FACTOR I US ORD 08/705,820 5965531 Abandoned PDF
NIMH E-179-1996-0-US-01 THERAPEUTIC USE OF PHAGE EXPRESSING TOXIN-BINDING AND/OR CYTOKINE- BINDING PROTEINS AND ELIMINATION OF GENES ASSOCIATED WITH LYSOGENY US 60/025,167 Abandoned
NIMH E-178-1996-0-US-01 DELETION OF LYSOGENY GENES AND TOXIN GENES FROM BACTERIOPHAGE USED IN THE EPIDEMIOLOGIC CONTROL OF BACTERIAL ILLNESS US 60/019,392 Abandoned
NCI E-025-1996-1-US-01 CYTOCHROME P-450 REPORTER GENE US ORD 08/697,329 5726041 Expired PDF
NCI E-025-1996-0-PCT-02 No_Patent_Title PCT PCT PCT/US96/013622 Expired
NCI E-068-1993-1-AU-03 METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION AU National Stage 68600/96 Abandoned
NCI E-068-1993-1-PCT-02 No_Patent_Title PCT PCT PCT/US96/13715 Expired
NCI E-068-1993-1-JP-06 METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION JP National Stage 509576/97 Abandoned
NCI E-068-1993-1-EP-05 METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION EP National Stage 96929056.8 Abandoned
NCI E-068-1993-1-CA-04 METHODS OF ASSESSING MHC CLASS I EXPRESSION AND PROTEINS CAPABLE OF MODULATING CLASS I EXPRESSION CA National Stage 2229938 Abandoned
NCI E-335-1994-1-US-01 Method of Screening for Agents that Delay a Cell Cycle and Composition s Comprising Era and an Analog of Wild-Type Era US 60/023,353 Abandoned
NIDDK E-175-1995-1-US-01 GATED RF PREAMPLIFIER FOR USE IN PULSED RADIOFREQUENCY ELECTRON PARAMAGNETIC RESONANCE AND MRI US ORD 08/699,383 5828216 Expired PDF
NCI E-143-1996-0-US-01 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION US 60/024,386 Abandoned
NCI E-206-1995-3-CA-03 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY CA National Stage 2229741 Abandoned
NCI E-206-1995-3-AU-02 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY AU National Stage 67765/96 Abandoned
NCI E-206-1995-3-DE-06 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY DE EP 96928205.2 Abandoned
NCI E-206-1995-3-FR-05 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY FR EP 96928205.2 Abandoned
NCI E-206-1995-3-EP-07 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY EP National Stage 96928205.2 Expired
NCI E-206-1995-3-GB-08 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY GB EP 96928205.2 Abandoned
NCI E-206-1995-3-PCT-01 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY PCT PCT COMB PCT/US1996/013286 Expired
NCI E-206-1995-3-JP-09 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY JP National Stage 509499/97 Abandoned
NCI E-188-1996-0-US-01 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME US 60/024,098 Abandoned
NIBIB E-235-1995-0-US-01 SPATIAL AND TEMPORAL CONTROL OF GENE EXPRESSION USING A HEAT SHOCK PROTEIN PROMOTER IN COMBINATION WITH LOCAL HEAT US 60/024,213 Abandoned
NCI E-046-1991-6-US-01 TRANSFORMED MAMMARY TUMOR-DERIVED CELL LINE HAVING AN INVASIVE/ METASTATIC PHENOTYPE INDUCED BY AUTOCRINE HEPATOCYTE GROWTH FACTOR... US 60/024,011 Abandoned
NCI E-144-1996-0-US-01 NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES US 60/023,931 Abandoned
NIEHS E-298-1999-0-US-01 Soluble Epoxide HydrolaseInhibitors as Novel Therapeutic Agents for Management of Systemic Hypertension US 60/023,397 Abandoned
NCI E-188-1995-1-US-02 ISOLATION OF AMPLIFIED GENES VIA CDNA SUBTRACTIVE HYBRIDIZATION US ORD 08/700,763 5827658 Expired PDF
NIDCR E-184-1995-2-PCT-01 No_Patent_Title PCT PCT COMB PCT/US96/012935 Abandoned
NCI E-188-1995-1-PCT-01 ISOLATION OF AMPLIFIED GENES VIA cDNA SUBTRACTIVE HYBRIDIZATION PCT PCT COMB PCT/US1996/012542 Abandoned
NCI E-100-1996-0-PCT-02 No_Patent_Title PCT PCT PCT/US96/12800 Abandoned
NCI E-100-1996-0-US-01 CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGS AS ANTIHERPETIC AGENTS US 60/023,565 Abandoned
NCI E-125-1995-0-US-01 BACTERIOPHAGE VECTORS FOR THE EXPRESSION AND DISPLAY OF HUMAN FAB FRAGMENTS US ORD 08/692,250 Abandoned
NCI E-113-1995-3-AU-04 DOMINANT NEGATIVE TRANSCRIPTION REGULATORY PROTEINS CREATED BY ACIDIC AMPHIPATHIC ALPHA-HELICAL EXTENSION OF THE LEUCINE ZIPPER AU National Stage 68423/96 Abandoned
NCI E-113-1995-2-US-01 EXTENSION OF A PROTEIN-PROTEIN INTERACTION SURFACE TO INACTIVATE THE FUNCTION OF A CELLULAR PROTEIN US ORD 08/690,011 5942433 Abandoned PDF
NCI E-022-2006-2-NZ-06 Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor NZ National Stage 282183 Expired
NCI E-113-1995-3-PCT-01 EXTENSION OF A PROTEIN-PROTEIN INTERACTION SURFACE TO INACTIVATE THE FUNCTION OF A CELLULAR PROTEIN PCT PCT COMB PCT/US1996/012590 Expired
NCI E-113-1995-3-JP-06 DOMINANT NEGATIVE TRANSCRIPTION REGULATORY PROTEINS CREATED BY ACIDIC AMPHIPATHIC ALPHA-HELICAL EXTENSION OF THE LEUCINE ZIPPER JP National Stage 507892/97 Abandoned
NCI E-113-1995-3-HK-03 DOMINANT NEGATIVE TRANSCRIPTION REGULATORY PROTEINS CREATED BY ACIDIC AMPHIPATHIC ALPHA-HELICAL EXTENSION OF THE LEUCINE ZIPPER HK National Stage 00100504.9 Abandoned
NCI E-113-1995-3-EP-02 DOMINANT NEGATIVE TRANSCRIPTION REGULATORY PROTEINS CREATED BY ACIDIC AMPHIPATHIC ALPHA-HELICAL EXTENSION OF THE LEUCINE ZIPPER EP National Stage 96928799.4 Abandoned
NCI E-113-1995-3-CA-05 DOMINANT NEGATIVE TRANSCRIPTION REGULATORY PROTEINS CREATED BY ACIDIC AMPHIPATHIC ALPHA-HELICAL EXTENSION OF THE LEUCINE ZIPPER CA National Stage 2228374 Abandoned